Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapy

被引:0
|
作者
Jun Won Kim [1 ]
Tae Hyung Kim [1 ]
Jie-Hyun Kim [2 ]
Ik Jae Lee [1 ]
机构
[1] Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine
[2] Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine
基金
新加坡国家研究基金会;
关键词
Chemoradiotherapy; Post-radiotherapy stenosis; High-dose radiotherapy; Cervical esophageal cancer;
D O I
暂无
中图分类号
R735.1 [食管肿瘤]; R737.33 [子宫肿瘤];
学科分类号
100214 ;
摘要
AIM To evaluate toxicity and treatment outcome of highdose radiotherapy(RT) for cervical esophageal cancer(CEC).METHODS We reviewed a total of 62 consecutive patients who received definitive RT for stage Ⅰ to Ⅲ cervical esophageal cancer between 2001 and 2015. Patients who received < 45 Gy, treated for lesions below sternal notch, treated with palliative aim, treated with subsequent surgical resection, or diagnosed with synchronous hypopharyngeal cancer were excluded. Treatment failures were divided into local(occurring within the RT field), outfield-esophageal, and regional [occurring in regional lymph node(s)] failures. Factors predictive of esophageal stenosis requiring endoscopic dilation were analyzed.RESULTS Grade 1, 2, and 3 esophagitis occurred in 19(30.6%), 39(62.9%), and 4 patients(6.5%), respectively, without grade ≥ 4 toxicities. Sixteen patients(25.8%) developed post-RT stenosis, of which 7 cases(43.8%) were malignant. Four patients(6.5%) developed tracheoesophageal fistula(TEF), of which 3(75%) cases were malignant. Factors significantly correlated with post-RT stenosis were stage T3/4(P = 0.001), complete circumference involvement(P < 0.0001), stenosis at diagnosis(P = 0.024), and endoscopic complete response(P = 0.017) in univariate analysis, while complete circumference involvement was significant in multivariate analysis(P = 0.003). A higher dose(≥ 60 Gy) was not associated with occurrence of postRT stenosis or TEF. With a median follow-up of 24.3(range, 3.4-152) mo, the 2 y local control, outfield esophageal control, progression-free survival, and overall survival(OS) rates were 78.9%, 90.2%, 49.6%, and 57.3%, respectively. Factors significantly correlated with OS were complete circumference involvement(P = 0.023), stenosis at diagnosis(P < 0.0001), and occurrence of post-RT stenosis or TEF(P < 0.001) in univariate analysis, while stenosis at diagnosis(P = 0.004) and occurrence of post-RT stenosis or TEF(P = 0.023) were significant in multivariate analysis. CONCLUSION Chemoradiation for CEC was well tolerated, and a higher dose was not associated with stenosis. Patients with complete circumferential involvement require close follow-up.
引用
收藏
页码:862 / 869
页数:8
相关论文
共 50 条
  • [31] High Control Rate for Lymph Nodes in Cervical Cancer Treated with High-Dose Radiotherapy using Helical Tomotherapy
    Kim, Y. J.
    Kim, J. Y.
    Yoo, S. H.
    Min, B. J.
    Chung, K. Z.
    Seo, S. S.
    Kang, S. B.
    Lim, M. C.
    Hwang, J. H.
    Yoo, H. J.
    Park, S. Y.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2013, 12 (01) : 45 - 51
  • [32] Evaluating the effect of reducing the high-dose volume on the toxicity of radiotherapy in the treatment of bladder cancer
    Mangar, S. A.
    Foo, K.
    Norman, A.
    Khoo, V.
    Shahidi, M.
    Dearnaley, D. P.
    Horwich, A.
    Huddart, R. A.
    CLINICAL ONCOLOGY, 2006, 18 (06) : 466 - 473
  • [33] High-dose radiotherapy for the treatment of inoperable non-small cell lung cancer
    Sura, Sonal
    Yorke, Ellen
    Jackson, Andrew
    Rosenzweig, Kenneth E.
    CANCER JOURNAL, 2007, 13 (04): : 238 - 242
  • [34] High-Dose Radiotherapy as Neoadjuvant Treatment in Non-Small-Cell Lung Cancer
    Allena, Aaron M.
    Shochat, Tzippy
    Flex, Dov
    Kramer, Mordechai R.
    Zer, Alona
    Peled, Nir
    Dudnik, Elizabeta
    Fenig, Eyal
    Saute, Milton
    ONCOLOGY, 2018, 95 (01) : 13 - 19
  • [35] Post-treatment magnetic resonance imaging predicts outcomes of maxillary sinus cancer treatment using super-selective intra-arterial infusion of high-dose cisplatin with concomitant radiotherapy (RADPLAT)
    Yamauchi, Hideomi
    Baba, Akira
    Ogino, Nobuhiro
    Matsushima, Satoshi
    Ashida, Hirokazu
    Nagaoka, Masato
    Ojiri, Hiroya
    AURIS NASUS LARYNX, 2024, 51 (04) : 631 - 635
  • [36] Comparison of two high-dose rate (HDR) brachytherapy regimens in treatment of cervical cancer
    Krishna, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S759 - S759
  • [37] Re: Predictors for Post-Treatment Biopsy Outcomes after Prostate Stereotactic Body Radiotherapy
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2021, 206 (02): : 477 - 477
  • [38] PROTON RADIOTHERAPY FOR PROSTATE CANCER IS NOT ASSOCIATED WITH POST-TREATMENT TESTOSTERONE SUPPRESSION
    Nichols, R. Charles, Jr.
    Morris, Christopher G.
    Hoppe, Bradford S.
    Henderson, Randal H.
    Marcus, Robert B., Jr.
    Mendenhall, William M.
    Li, Zuofeng
    Williams, Christopher R.
    Costa, Joseph A.
    Mendenhall, Nancy P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (03): : 1222 - 1226
  • [39] Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy
    Joseph, Nuradh
    McWilliam, Alan
    Kennedy, Jason
    Haslett, Kate
    Mahil, Jasmin
    Gavarraju, Abhilash
    Mistry, Hitesh
    Van Herk, Marcel
    Faivre-Finn, Corinne
    Choudhury, Ananya
    RADIOTHERAPY AND ONCOLOGY, 2019, 135 : 115 - 119
  • [40] TREATMENT OF ESOPHAGEAL CAUSTIC INJURIES - EXPERIENCE WITH HIGH-DOSE DEXAMETHASONE
    CADRANEL, S
    SCAILLON, M
    GOYENS, P
    RODESCH, P
    PEDIATRIC SURGERY INTERNATIONAL, 1993, 8 (02) : 97 - 102